NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,558,000 | +60.3% | 90,704 | +2.2% | 0.20% | -24.4% |
| Q3 2015 | $972,000 | -19.4% | 88,717 | -19.1% | 0.27% | -38.6% |
| Q1 2015 | $1,206,000 | +581.4% | 109,612 | +859.8% | 0.43% | +365.6% |
| Q4 2014 | $177,000 | -23.7% | 11,420 | -36.8% | 0.09% | +43.1% |
| Q2 2014 | $232,000 | +48.7% | 18,062 | +31.7% | 0.06% | +124.1% |
| Q4 2013 | $156,000 | -81.6% | 13,710 | -83.1% | 0.03% | -84.7% |
| Q3 2013 | $846,000 | – | 81,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |